View all data FOR FREE!
Create an account today, no credit card required.
| Issue Type | XXXX |
|---|---|
| Country | Japan |
| Industry | XXXX |
| Region | XXXX |
| Maturity Date | 2028-11-26 |
| Par Value | 200000 |
| Callable | XXXX |
| Next Call Date | XXXX |
| Call Type | XXXX |
| Call Price (%) | XXXX |
| Series | XXXX |
| Class | XXXX |
| Maturity Structure | XXXX |
| Amount Outstanding (mil) | 1728.00 |
| Coupon | 5 |
|---|---|
| Coupon Type | XXXX |
| Coupon Frequency | XXXX |
| First Coupon Date | XXXX |
| Last Coupon Date | XXXX |
| Sinking Fund | XXXX |
|---|---|
| Security | XXXX |
| Subordination | XXXX |
| Debt Type | XXXX |
| Issue Date | XXXX |
|---|---|
| Dated Date | XXXX |
| Issue Size (mil) | 1728.000 |
| Min. Piece | XXXX |
| Min. Increment | XXXX |
This Takeda Pharmaceutical Co corporate note has a 5.00% fixed rate coupon paid on a semi-annual basis. It was issued on December 17, 2019 with an issue size of 1728.00 million USD and matures on November 26, 2028 with a last coupon date of May 26, 2028. |
Takeda Pharmaceutical Co., founded in 1781 and headquartered in Osaka, Japan, is a global leader in the biopharmaceutical industry focused on delivering innovative medicines to patients worldwide. The company specializes in therapeutic areas such as oncology, neuroscience, gastrointestinal conditions, and rare diseases, with a strong portfolio of key products including blood cancer treatments and immunology therapies.